These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2677642)

  • 1. [Use of semisynthetic human insulin in juvenile insulin-dependent diabetes mellitus].
    Sacchetti C; Foco A; David O; Balboni R; Gargano P; Cerutti F; Baratono S
    Minerva Pediatr; 1989 May; 41(5):221-2. PubMed ID: 2677642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monocomponent insulins in the treatment of juvenile diabetes].
    Kopecký A; Vavrinec J; Kimlová I; Pospísilová D
    Cesk Pediatr; 1984 Apr; 39(4):223-5. PubMed ID: 6375877
    [No Abstract]   [Full Text] [Related]  

  • 3. Transfer from purified porcine insulins to semisynthetic human insulins decreases insulin antibodies and circulating immune complexes in diabetic children and adolescents. A two-year follow-up.
    Dorchy H; Duchateau J; Bosson D; D'Hooge D
    Diabete Metab; 1989; 15(3):107-10. PubMed ID: 2668052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of a semisynthetic human insulin and swine insulin].
    Sailer D; Volkholz HJ; Kolb S; Pichl J
    Fortschr Med; 1986 Apr; 104(16):340-2. PubMed ID: 3519402
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduction in insulin antibodies 42 months after transfer from porcine to human monocomponent insulins.
    Virgili F; Frigato F; Magnanini PG; Coronel GA; Iavicoli M
    Diabetes Res; 1988 Sep; 9(1):19-20. PubMed ID: 3071441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of semisynthetic human insulin.
    Rogala H; Lawecki J; Czyzyk A
    Acta Med Pol; 1986; 27(1-2):45-50. PubMed ID: 3551505
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison of semisynthetic human insulin and porcine insulin in diabetic patients with or without circulating anti-insulin antibodies].
    Vandeleene B; Ketelslegers JM; Lambert AE
    Acta Clin Belg; 1983; 38(6):360-8. PubMed ID: 6369853
    [No Abstract]   [Full Text] [Related]  

  • 8. Insulin antibodies in diabetic children treated with monocomponent porcine insulin from the onset: relationship to B-cell function and partial remission.
    Ludvigsson J
    Diabetologia; 1984 Feb; 26(2):138-41. PubMed ID: 6370760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intensified insulin therapy in children and adolescents with labile diabetes mellitus].
    Lebedev NB; Shcherbacheva LN; Kniazeva AP; Lobanova AM
    Pediatriia; 1989; (11):75-9. PubMed ID: 2691980
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of human versus porcine insulin in treatment of diabetes in children.
    Greene SA; Smith MA; Cartwright B; Baum JD
    Br Med J (Clin Res Ed); 1983 Nov; 287(6405):1578-9. PubMed ID: 6416510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human (semisynthetic) insulin and porcine insulin in the treatment of non-insulin-dependent diabetes. A double-blind, comparative clinical trial.
    Moffitt PS; Colagiuri S; Miller JJ; Hall CA
    Med J Aust; 1984 Feb; 140(4):200-2. PubMed ID: 6363896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood glucose lowering by human insulins and highly purified porcine insulin. Metabolic study in insulin-injecting diabetics].
    Sailer D; Volkholz HJ; Pichl J
    Fortschr Med; 1985 May; 103(19):527-30. PubMed ID: 3891564
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative double-blind trial of the effectiveness and antigenicity of semisynthetic human insulin and purified porcine insulin in newly treated diabetic subjects.
    Larkins RG; Zajac J; Saunders R; Read A; Hopper JL
    Aust N Z J Med; 1986 Apr; 16(2):206-10. PubMed ID: 3530226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Miscibility of semisynthetic human ultralente insulin with short-acting insulin in insulin-dependent diabetic patients.
    Lunetta M; di Mauro M; Crimi S; Sudano L; Mughini L
    Acta Diabetol Lat; 1988; 25(3):263-9. PubMed ID: 3071068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of human and porcine insulin therapies in children with newly diagnosed diabetes mellitus.
    Zuppinger K; Aebi C; Fankhauser S; Herz G; Zurbrügg RP; Schopfer K; Neri TM
    Diabetologia; 1987 Dec; 30(12):912-5. PubMed ID: 3325323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of juvenile diabetics with highly purified insulin preparations--effect on the formation insulin antibodies and metabolic compensation].
    Michalková D; Bircák J; Cársky J; Kolár J; Sílesová J; Zmeková-Jancová E
    Cesk Pediatr; 1985 Apr; 40(4):219-23. PubMed ID: 3893762
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary allergy to monocomponent porcine insulin.
    Yap PK
    Postgrad Med J; 1985 Jul; 61(717):629-30. PubMed ID: 3161014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Human monocomponent insulin in the metabolic control of diabetes mellitus in pediatric patients].
    Romano C; Cotellessa M; Micalizzi C
    Minerva Endocrinol; 1984; 9(2):151-8. PubMed ID: 6390130
    [No Abstract]   [Full Text] [Related]  

  • 19. [Quality of insulin preparations and their effect on the utilization of insulin in juvenile diabetics].
    Kolár J; Michalková D
    Cesk Pediatr; 1985 Dec; 40(12):697-700. PubMed ID: 3910273
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood glutathione in various phases of insulin-dependent diabetes mellitus in children.
    Hägglöf B; Holmgren G; Falkmer S
    Ups J Med Sci; 1981; 86(1):93-7. PubMed ID: 7029853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.